Wet AMD is a highly prevalent disease, with more than 4 million individuals expected to be affected in the next five years in certain major markets, including the U.S., the EU and Japan. The disease ...

EMERYVILLE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease ...

4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.

We are currently undergoing maintenance on some services, which may temporarily affect access to subscription accounts and the E-edition. We apologize for any inconvenience and appreciate your ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. First dates are just the beginning, and many of us would not handle past experiences the same way now as we did then. Get up ...

We have a home for your research. Our community journals and sections cover more than 1,700 academic disciplines. Visit our press office for key media contact information, as well as Frontiers’ media ...